"Immunostaging" of patients with prostatic cancer: correlation of "immunostage" and clinical stage. An interim report
Ablin, R.J.; Guinan, P.D.; Sundar, B.; Bush, I.M.
Current Therapeutic Research 20(5): 674-679
1976
ISSN/ISBN: 0011-393X PMID: 825353 Document Number: 104519
Document emailed within 1 workday
Related Documents
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258Pavone-Macaluso, M.; Lund, F.; Mulder, J.H.; Smith, P.H.; De Pauw, M.; Sylvester, R. 1980: EORTC protocols in prostatic cancer. An interim report Scandinavian Journal of Urology and Nephrology. Supplementum 55: 163-168
Ross, J.S.; Figge, H.L.; Bui, H.X.; del Rosario, A.D.; Fisher, H.A.; Nazeer, T.; Jennings, T.A.; Ingle, R.; Kim, D.N. 1994: E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 7(8): 835-841
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Jörgensen, P.E.; Berild, G.H.; Bruun, E.; Weis, N.; Nielsen, K.; Gundersen, H.J. 1988: Stereological estimates of nuclear volume correlated with clinical stage and progression of prostatic cancer: clinical aspects Scandinavian Journal of Urology and Nephrology. Supplementum 110: 131-135
Ikeda, M.; Inagaki, Y.; Iimura, O.; Kuramoto, K.; Takeda, T. 1986: Clinical evaluation of bisoprolol in patients with hypertension: interim report Journal of Cardiovascular Pharmacology 8 Suppl. 11: S139-S142
Nakanishi, S.; Gotou, T.; Sawada, A.; Shibasaki, N.; Ishitoya, T.; Okumura, K. 2009: Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate Hinyokika Kiyo. Acta Urologica Japonica 55(1): 5-8
Jacobs, P.; King, H.S.; Cassidy, F.; Dent, D.M.; Harrison, T. 1981: VP-16-213 in the treatment of stage III and IV diffuse lymphocytic lymphoma of the large cell (histiocytic) variety: an interim report Cancer Treatment Reports 65(11-12): 987-993
Bai, Y.-q.; Liu, X.-j.; Wang, Y.; Ge, F.-j.; Zhao, C.-h.; Fu, Y.-l.; Lin, L.; Xu, J.-m. 2013: Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer Zhonghua Zhong Liu Za Zhi 35(9): 666-671
Karasawa, T. 1988: Interim report on home care by the Office of Comprehensive National Health Care Planning: the interim report and subsequent developments Japanese Journal for Public Health Nurse 44(9): 814-817
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Suzuki, T.; Shimizu, T.; Imai, K.; Yamanaka, H.; Suzuki, K.; Takahashi, H. 1989: Studies of progressive factors of stage a prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(2): 259-263
Hata, M. 1988: Stage D1 prostatic cancer benefited by a single regimen of Estracyt Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(5): 1787-1790
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379
Takeuchi, S.; Fukui, I.; Higashi, Y.; Andoh, M.; Kihara, K.; Kitahara, S.; Horiuchi, S.; Oshima, H. 1989: Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 35(9): 1513-1517
Badalament, R.A.; Drago, J.R. 1989: Correlation of prostatic specific antigen with Gleason grade in prostate cancer In Vivo 3(6): 381-382
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Pippione, M.; Aloi, F.G.; Stuardi, C.; Zina, G. 1986: Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985) Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(5): 311-326
Turowski, G.; Konieczna, A.; Horeczy, M. 1991: Immune reactivity and clinical stage of patients with laryngeal cancer Materia Medica Polona. Polish Journal of Medicine and Pharmacy 23(3): 182-186
Metzger, U.; Laffer, U.; Aeberhard, P.; Arigoni, M.; Arma, S.; Barras, J.; Egeli, R.; Martinoli, S.; Mueller, W.; Schweizer, W. 1990: Randomized multicenter trial of adjuvant intraportal chemotherapy for colorectal cancer (SAKK 40/81). An interim report Acta Chirurgica Scandinavica 156(6-7): 467-474
Barrack, E.R.; Brendler, C.B.; Walsh, P.C. 1987: Steroid receptor and biochemical profiles in prostatic cancer: correlation with response to hormonal treatment Progress in Clinical and Biological Research 243a: 79-97